Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
Clinical trial NCT02569632 · COMPLETED
Trial details
- NCT number
- NCT02569632
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.